GCC1 and triple-negative breast carcinoma: To date, only one study of tiRNA-Gly-GCC-1 in another cancer was reported which demonstrated that tiRNA-Gly-GCC-1, upregulated in hypoxia-treated triple-negative breast cancer cell lines, might act as a regulatory factor involved in the hypoxia-induced chemoresistance [14].